deucravacitinib
bms
[' psa', 'deucra']
#spa posters #acr22 2133. baseline biomarkers predict better responses to deucravacitinib ph 2 trial in psa pts with higher expression of baseline serum il-23 pathway biomarkers were more likely to benefit in their joint and skin manifestations #acrambassador 
Rheumatologist | Epi | ASAS | Twitter Ambassador (ACR/ ARD-BMJ) | ArLAR ARCH President | St Joseph University & HDF Beirut | Love Music | Travel Books